March 1, 2011 – C5•6 Technologies Inc. is pleased to announce that it has recently been awarded a SBIR Phase I grant to fund additional research and development.
The National Institutes of Health has awarded C5•6 Technologies $227,829 as a Small Business Innovation Research grant to be used to develop research tools with the potential to improve human health. The grant includes funding for the development of new enzymatic tools that will subsequently enable discovery and characterization of new therapeutic agents against life threatening biofilms. Specifically, scientists from C5•6 Technologies, in partnership with researchers at the Dartmouth Medical School, will identify enzymes active on microbial biofilms. This grant will enable discovery of new enzyme catalysts that can be studied for a variety of therapeutic applications in the future.